Abstract
In this study, immunizations at 2 weeks vs. 6 weeks intervals, with an HIV-1 envelope protein in adjuvants, through intra-nasal (IN), intra-muscular (IM), IN followed by IM (IN/IM) and IM/IN, were compared for induction of mucosal and systemic immune responses. IN/IM immunizations at 2, but not at 6, week intervals induced the highest mucosal and systemic immune responses compared to other immunization routes. Following a resting memory phase, IN boosting of IN/IM-immunized mice, compared to IM-boosting of IM-immunized mice, induced increased IgA responses. Thus, depending on the immunization intervals, IN/IM may be more effective than IM immunizations for short- and long-term immunity.
Publication types
-
Comparative Study
-
Research Support, N.I.H., Extramural
MeSH terms
-
AIDS Vaccines / administration & dosage*
-
AIDS Vaccines / genetics
-
AIDS Vaccines / immunology*
-
Administration, Intranasal
-
Animals
-
Cytokines / biosynthesis
-
Female
-
HIV Antibodies / analysis
-
HIV Envelope Protein gp160 / administration & dosage*
-
HIV Envelope Protein gp160 / genetics
-
HIV Envelope Protein gp160 / immunology*
-
Immunity, Mucosal*
-
Immunization, Secondary
-
Immunoglobulin A / blood
-
Immunoglobulin G / blood
-
Immunologic Memory*
-
Injections, Intramuscular
-
Mice
-
Mice, Inbred BALB C
-
T-Lymphocytes / immunology
-
Time Factors
Substances
-
AIDS Vaccines
-
Cytokines
-
HIV Antibodies
-
HIV Envelope Protein gp160
-
Immunoglobulin A
-
Immunoglobulin G